# OptimizeRx Corp: Form SCHEDULE 13D, filed Feb 5, 2025

- Company: [OptimizeRx Corp](/companies/oprx.md) (CIK 1448431)
- Form: SCHEDULE 13D
- Filed: 2025-02-05
- Accepted by EDGAR: Feb 5, 2025, 16:41 ET
- Period: not reported
- Accession: 0000950170-25-014245
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1448431/000095017025014245/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1448431/000095017025014245/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1448431/000095017025014245/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Feb 5, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-014245. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.